主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PRME
#2354
Prime Medicine, Inc. Common Stock
4.6
2
+7.94%
版块:
基础:
利润货币:
日范围
年范围
日变化
+7.94%
每月变动
+6.21%
6个月变化
+35.48%
年变化
+87.04%
前一天收盘价
4.2
8
Open
4.6
2
Bid
Ask
Low
4.6
2
High
4.6
2
交易量
111
市场
股票
医疗保健
PRME
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2022
2023
2024
TTM
Dividends per share
—
—
—
—
Dividend yield %
—
—
—
—
Payout ratio %
—
—
—
—
新闻
Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates
Prime Drink Group完成私募首轮融资
Prime Drink Group completes first closing of private placement
Prime: Maintaining "Buy" On Solidified Catalysts For Wilson's Disease And Beyond
Prime Drink Group宣布私募融资最高达500万美元
Prime Drink Group announces private placement to raise up to $5 million
高盛重申对Prime Medicine股票的"早期生物科技"评级
Goldman Sachs reiterates Early-Stage Biotech rating on Prime Medicine stock
Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates
Prime Medicine appoints Matthew Hawryluk as chief business officer
NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates
Prime Medicine Momentum Amid Pipeline Progress: Why I Choose To 'Hold' For Now (PRME)